KPIs & Operating Metrics(New)
Assets By Segment AnnualAst Revenue By CategoryAst Revenue By Category AnnualBacklogBacklog AnnualBacklog By Segment AnnualBreakdown Of AssetsCapital Expenditure By SegmentCost Of Revenue By Business VerticalEmployee StatisticsGross Margin %Gross Margin Annual %Gross Margin By Business Vertical %Gross Margin By Business Vertical Annual %Gross ProfitGross Profit AnnualGross Profit By Business VerticalGross Profit By Business Vertical AnnualHealthcare Revenue By CategoryHealthcare Revenue By Category AnnualIncome Before Income TaxLifescience Revenue By CategoryLifescience Revenue By Category AnnualNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Income By SegmentOperating Income By Segment AnnualOperating Margin By Segment %Operating Margin By Segment Annual %Opex As A % Of Total Revenue %OPEX SegregationProperty And Equipment, Net BreakdownProperty, Plant And Equipment By GeographyRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue By TypeRevenue By Type %Revenue By Type AnnualRevenue By Type Annual %Total Cost Of Revenue
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Steris (STE) Gross Profit (2019 - 2026)

Steris has reported Gross Profit over the past 8 years, most recently at $655.5 million for Q4 2025.

  • Quarterly results put Gross Profit at $655.5 million for Q4 2025, up 7.41% from a year ago — trailing twelve months through Dec 2025 was $2.6 billion (up 9.65% YoY), and the annual figure for FY2025 was $2.4 billion, up 8.32%.
  • Gross Profit for Q4 2025 was $655.5 million at Steris, up from $645.9 million in the prior quarter.
  • Over the last five years, Gross Profit for STE hit a ceiling of $655.5 million in Q4 2025 and a floor of $379.8 million in Q1 2021.
  • Median Gross Profit over the past 5 years was $553.2 million (2023), compared with a mean of $546.4 million.
  • Biggest five-year swings in Gross Profit: soared 55.59% in 2021 and later fell 11.14% in 2022.
  • Steris' Gross Profit stood at $538.1 million in 2021, then fell by 11.14% to $478.2 million in 2022, then rose by 17.11% to $560.0 million in 2023, then increased by 8.98% to $610.3 million in 2024, then increased by 7.41% to $655.5 million in 2025.
  • The last three reported values for Gross Profit were $655.5 million (Q4 2025), $645.9 million (Q3 2025), and $628.0 million (Q2 2025) per Business Quant data.